clinic
microbiolog
laboratori
increasingli
invest
next
gener
sequenc
ng
recent
year
clinic
applic
includ
exampl
outbreak
investig
viral
type
drug
resist
analysi
pathogen
shotgun
metagenom
microbiom
ampliconbas
metagenom
particular
shotgun
metagenom
use
ng
promis
techniqu
analyz
dna
rna
microbi
materi
patient
sampl
eg
mostli
use
research
set
increasingli
use
clinic
realm
well
notabl
support
diagnosi
viral
infect
unknown
aetiolog
system
infect
viru
discoveri
clinic
metagenom
complex
workflow
includ
sever
critic
step
sampl
prepar
report
pathogen
particular
heavili
reli
bioinformat
data
process
analysi
interpret
effort
made
benchmark
bioinformat
tool
detect
bacteria
patient
sampl
intern
laboratori
valid
clinic
metagenom
assay
pathogen
detect
cerebrospin
fluid
establish
guidelin
valid
clinic
metagenom
assay
also
use
spike
sampl
artifici
data
switzerland
swiss
institut
bioinformat
sib
lead
coordin
field
bioinformat
sib
launch
nationwid
work
group
wg
ng
microb
type
character
aim
harmon
ng
practic
within
swiss
clinic
microbiologyvirolog
laboratori
notabl
regard
bioinformat
wg
current
compris
clinic
bioinformat
expert
swiss
univers
hospit
associ
clinic
microbiologyvirolog
lab
canton
hospit
swiss
feder
institut
nbcprotect
spiez
laboratori
well
research
group
swiss
academ
institut
met
eight
time
facetofac
sinc
septemb
follow
initi
detail
survey
ng
practic
swiss
hospit
virolog
lab
highlight
varieti
methodolog
softwar
use
across
countri
wg
suggest
sib
organ
viral
metagenom
ring
trial
first
step
toward
benchmark
current
workflow
use
clinic
set
defin
common
best
practic
importantli
pave
way
toward
qualitycontrol
routin
implement
ng
clinic
virolog
laboratori
particip
extern
qualiti
assess
eqa
program
viral
metagenom
ring
trial
therefor
design
qualiti
control
test
pathogen
identif
viral
metagenom
data
main
object
benchmark
exist
workflow
current
use
swiss
hospit
clinic
virolog
laboratori
quantifi
differ
among
particip
laboratori
identifi
improv
train
might
need
foster
increas
qualiti
develop
common
best
practic
ng
viral
metagenom
present
result
viral
metagenom
ring
trial
rt
run
particip
receiv
questionnair
methodolog
use
cf
section
five
sampl
consist
human
blood
plasma
spike
known
virus
cf
section
sib
common
databas
cf
section
particip
return
fill
questionnair
methodolog
use
pipelin
done
first
join
rt
either
increment
raw
read
sequenc
fastq
preprocessingclassifi
read
eg
bam
bga
align
read
eg
tsv
use
kmerbas
approach
identifi
virus
associ
metric
viru
metric
file
virusdatabaseidnumberofreadspercentcoveragegenomesizea
technic
lab
report
contain
result
interpret
methodolog
detail
note
end
use
classifi
read
increment
bam
bga
file
ground
truth
read
unknown
particip
alreadi
ask
comput
summari
statist
includ
read
count
viru
metric
file
particip
receiv
thirteen
fastq
dataset
label
random
number
consist
five
sampl
increment
sequenc
particip
eight
insilico
gener
fastq
dataset
cf
section
sib
common
databas
cf
section
particip
return
output
increment
except
raw
read
fastq
addit
viru
metric
tabl
updat
contain
two
addit
column
report
viru
would
report
clinician
otherwis
ii
comment
sequenc
annot
complet
viral
genom
around
download
genbank
queri
vrl
divis
complet
genom
sequenc
subject
screen
base
entri
annot
follow
criteria
sequenc
must
complet
genom
ii
viru
must
vertebr
host
iii
sequenc
must
contain
unknown
nucleotid
entri
sort
clade
virus
known
speci
level
group
genu
virus
known
genu
level
group
famili
etc
clade
contain
fewer
two
entri
drop
clade
allow
exceed
entri
entri
drawn
random
clade
excess
entri
discard
entri
split
test
train
set
attribut
everi
fifth
entri
test
set
other
train
set
train
set
provid
particip
test
set
use
gener
insilico
dataset
increment
explain
section
common
databas
consist
train
set
provid
three
version
one
refer
viral
sequenc
one
supplement
nontargetcontamin
sequenc
bacteria
fungi
bacteriophag
etc
one
supplement
human
sequenc
order
make
sure
common
databas
could
seamlessli
integr
particip
analysi
pipelin
header
fasta
file
gener
compli
condit
indic
particip
registr
form
sibprovid
common
databas
avail
dataset
note
howev
cours
ring
trial
sever
refer
viral
databas
becom
avail
scientif
commun
well
eg
virosauru
curat
databas
avail
request
philippelemerci
sibswiss
person
commun
refer
viral
databas
rvsb
five
differ
sampl
prepar
increment
three
sampl
consist
unfilt
healthi
donor
plasma
blutspend
schlieren
switzerland
spike
four
virus
obtain
inhous
cell
cultur
supernat
fold
serial
dilut
plasma
human
betaherpesviru
mastadenoviru
benteroviru
cinfluenza
viru
order
control
dilut
total
nucleic
acid
extract
nuclisen
emag
marci
l
etoil
franc
follow
qpcr
triplic
specif
primer
ct
valu
four
virus
rang
dilut
ml
aliquot
store
shipment
dri
ice
addit
viral
multiplex
control
nation
institut
biolog
standard
control
nibsc
prepar
accord
protocol
reagent
contain
dilut
follow
virus
human
plasma
bkv
cmv
ebv
jcv
vzv
lyophil
content
six
vial
resuspend
pool
mix
ml
aliquot
store
shipment
dri
ice
ct
valu
ten
virus
rang
final
nibsc
neg
control
prepar
pool
content
two
vial
ml
mix
ml
aliquot
store
shipment
dri
ice
result
five
identicallylook
sampl
label
number
one
five
tabl
ship
frozen
contact
person
particip
laboratori
instruct
keep
sampl
process
select
five
fastq
dataset
among
data
produc
particip
increment
five
dataset
consist
fold
serial
dilut
spike
sampl
nibsc
neg
control
twice
nibsc
viral
multiplex
control
sequenc
two
differ
laboratori
sinc
pipelin
h
one
sequenc
dna
rna
separ
select
five
dataset
among
data
provid
remain
three
sequenc
center
ie
pipelin
e
make
sure
everi
particip
laboratori
could
use
exist
workflow
without
integr
result
two
separ
analys
tabl
column
pipelin
show
pipelin
pick
fastq
dataset
set
singleend
compar
pairedend
read
length
also
indic
tabl
column
set
send
dataset
fastq
header
anonym
sequenc
qualiti
check
fastqc
compar
output
result
provid
dataset
increment
compar
expect
make
sure
particip
laboratori
swap
sampl
mistak
read
produc
artillumina
use
sourc
sequenc
fasta
format
test
set
common
databas
sequenc
provid
particip
cf
section
includ
sequenc
viral
origin
also
sequenc
contamin
bacteri
human
known
contamin
actual
origin
read
commun
particip
mask
fastq
header
devis
two
challeng
four
dataset
repres
total
eight
dataset
particip
inform
dataset
contain
virus
dataset
label
random
number
tabl
column
label
first
challeng
consist
dataset
ii
contain
preset
number
sequenc
one
strain
follow
virus
addit
contamin
explain
human
mastadenoviru
ahuman
coronaviru
acut
respiratori
syndromerel
coronaviru
sar
influenza
b
virushuman
respiroviru
human
rubulaviru
human
orthopneumoviru
human
respiratori
syncyti
viru
human
metapneumovirusnorwalk
virusrotaviru
ahepaciviru
c
hcv
perform
fold
serial
dilut
fold
serial
dilut
increas
mutat
rate
artillumina
fold
serial
dilut
obtain
four
dataset
tabl
second
challeng
consist
dataset
iii
contain
preset
number
sequenc
one
strain
follow
virus
addit
contamin
explain
human
betaherpesviru
cmv
human
alphaherpesviru
human
betaherpesviru
parechoviru
ahuman
alphaherpesviru
vzv
jc
virusbk
viru
perform
fold
serial
dilut
fold
serial
dilut
increas
mutat
rate
artillumina
fold
serial
dilut
obtain
four
dataset
tabl
note
dilut
dataset
regener
test
set
fasta
sequenc
simpli
subsampl
correspond
fastq
dataset
script
use
gener
insilico
dataset
avail
dataset
addit
eight
dataset
gener
sever
combin
set
singl
one
compar
pairedend
two
read
length
bp
aim
particip
could
choos
set
correspond
actual
workflow
howev
order
ensur
fair
among
particip
decid
normal
number
read
per
viru
read
length
read
certainli
advantag
viru
detect
identif
come
cost
result
necessari
tradeoff
enabl
routin
implement
clinic
set
thu
gener
dataset
made
sure
provid
viral
inform
measur
total
number
base
viral
origin
ie
number
read
viral
origin
x
averag
read
length
ident
set
exampl
dataset
gener
bp
contain
read
viral
origin
compar
dataset
gener
bp
addit
fraction
contamin
human
nonhuman
origin
invari
fix
total
number
read
respect
leav
read
viral
origin
dataset
exact
number
read
dataset
found
tabl
dataset
provid
increment
avail
dataset
ring
trial
organ
particip
three
month
perform
increment
februari
may
month
perform
increment
juli
septemb
laboratori
possibl
particip
one
sever
pipelin
pipelin
refer
specif
combin
laboratori
bioinformat
workflow
particip
ask
use
ident
set
given
pipelin
increment
use
inhous
sibprovid
databas
four
laboratori
particip
increment
total
seven
pipelin
five
laboratori
particip
increment
total
seven
pipelin
well
one
drop
one
join
increment
methodolog
use
eight
pipelin
briefli
describ
tabl
pipelin
assign
capit
letter
sampl
number
name
output
file
particip
ask
prefix
filenam
use
convent
pipelinelett
samplenumb
eg
bam
file
sampl
obtain
pipelin
addit
insilico
dataset
particip
also
specifi
sequenc
paramet
chosen
list
provid
eg
refer
pairedend
read
bp
particip
answer
short
questionnair
methodolog
use
see
section
questionnair
pipelinespecif
passwordprotect
pipelinespecif
token
end
questionnair
particip
direct
link
upload
small
file
synccom
passwordprotect
larger
data
file
fastq
bam
particip
could
also
submit
use
switchfilesend
voucher
gb
switch
protect
cloud
swiss
academ
commun
questionnair
consist
question
cover
storagesampl
prepar
enrich
dnarna
extract
quantif
qualiti
assessmentlibrari
preparationsequencingbioinformat
read
preprocess
methodolog
list
question
avail
dataset
viru
metric
file
convert
csv
format
typo
header
manual
correct
match
expect
header
increment
particip
ask
mention
viru
metric
file
whether
would
report
viru
report
column
howev
extrem
handi
automat
analys
result
therefor
decid
manual
add
report
column
metric
file
return
particip
reli
report
transcrib
inform
ncbi
access
number
mention
report
simpli
set
correspond
viru
metric
file
report
column
sinc
metric
file
contain
databaseid
field
ncbi
access
number
report
mention
uninterpret
exclud
consid
report
unfortun
report
mention
ncbi
access
number
viru
name
therefor
manual
go
virus
metric
file
identifi
virus
actual
one
report
final
report
increment
manual
step
remov
directli
ask
particip
add
report
column
metric
file
expect
virus
sampl
known
sinc
virus
multipl
name
sinc
requir
specieslevel
resolut
assess
perform
defin
regular
express
repres
variou
name
subtyp
expect
virus
tabl
use
ncbi
access
number
provid
report
viru
metric
file
ie
report
column
set
retriev
viru
full
name
use
ncbi
eutil
api
full
viru
name
map
regular
express
repres
expect
posit
tabl
order
determin
number
true
posit
tp
fals
neg
fn
fals
posit
fp
identifi
pipelin
thu
result
sensit
precis
note
use
viru
name
provid
particip
metric
file
inhous
databas
viru
name
sometim
correspond
higherlevel
resolut
eg
genu
particip
laboratori
found
conveni
report
virus
present
sampl
gener
term
clinician
therebi
reflect
actual
capac
laboratori
narrow
viru
speci
level
spike
sampl
ie
nonneg
perform
measur
harmon
mean
sensit
precis
sensit
also
known
recal
true
posit
rate
measur
tp
tp
fn
tp
true
posit
fn
fals
neg
thu
sensit
reflect
fraction
true
posit
among
expect
virus
found
hand
precis
also
known
posit
predict
valu
measur
tp
tp
fp
therefor
reflect
fraction
true
posit
among
predict
posit
analysi
carri
rubi
r
r
core
team
script
fals
neg
map
familylevel
resolut
order
abl
compar
fals
posit
identifi
across
pipelin
tabl
sampl
report
virus
ie
report
viru
metric
file
estim
depth
coverag
use
follow
formula
depth
number
read
map
viru
averag
read
lengthviru
genom
size
sampl
calcul
mean
depth
coverag
take
harmon
mean
depth
across
report
virus
sampl
analysi
script
avail
dataset
increment
particip
receiv
five
biolog
sampl
one
neg
sampl
pipelin
differ
way
sometim
bioinformat
level
cf
tabl
inde
seven
pipelin
actual
five
set
submit
fastq
dataset
four
sequenc
center
pipelin
e
f
j
base
common
fastq
dataset
observ
signific
variabl
perform
across
pipelin
shown
figur
pipelin
h
sensit
precis
three
dilut
spike
sampl
result
fscore
equal
one
follow
e
f
j
b
thu
spike
sampl
increment
pipelin
base
map
achiev
better
perform
base
kmer
cf
tabl
observ
howev
perform
nibsc
multiplex
viral
control
gener
poorer
although
viru
concentr
similar
rang
dilut
spike
sampl
sampl
mappingbas
method
systemat
outperform
kmersbas
method
poorer
perform
viral
multiplex
may
explain
larg
number
differ
virus
fact
sampl
resembl
less
real
clinic
sampl
increment
four
sampl
increment
repres
figur
result
sampl
increment
compar
increment
despit
particip
start
fastq
dataset
still
observ
great
variabl
perform
spike
sampl
increment
addit
notic
pipelin
e
abl
replic
result
given
dataset
anonym
header
pipelin
achiev
differ
perform
fastq
dataset
increment
compar
addit
gener
eight
insilico
dataset
describ
materi
method
plot
perform
across
pipelin
figur
contrari
increment
pipelin
stood
top
perform
dataset
ii
particularli
challeng
sensit
precis
level
hand
particip
achiev
gener
good
precis
dataset
iii
low
sensit
shown
explain
overal
perform
measur
gener
better
dataset
iii
ii
figur
interestingli
higher
mutat
rate
sampl
four
one
triangl
figur
impact
overal
perform
gener
compar
correspond
dilut
squar
figur
serial
dilut
howev
result
decreas
perform
identifi
virus
sampl
increment
avail
figur
order
better
understand
drive
perform
plot
perform
function
mean
depth
per
report
viru
figur
cf
materi
method
interestingli
increment
observ
posit
correl
mean
depth
per
viru
perform
plateau
around
figur
order
see
mean
depth
directli
link
sequenc
depth
plot
figur
perform
function
total
number
sequenc
read
interestingli
observ
pipelin
h
sequenc
time
read
rest
pipelin
inde
translat
well
order
magnitud
higher
depth
per
viru
compar
pipelin
figur
without
increas
perform
versu
pipelin
thu
type
sampl
provid
increment
appear
combin
perform
bioinformat
pipelin
sequenc
read
per
sampl
may
suffici
viru
identif
sampl
type
applic
eg
stool
sampl
virus
discoveri
may
howev
requir
sequenc
set
eg
deeper
sequenc
rationalis
cost
routin
use
metagenom
import
factor
take
account
addit
reduc
turnaround
time
also
critic
enabl
clinic
impact
technolog
foster
adopt
clinic
plot
figur
perform
function
turnaround
time
sampl
prepar
report
sampl
increment
interestingli
observ
correl
pipelin
achiev
great
perform
short
turnaround
time
h
day
compar
pipelin
increment
particip
receiv
two
fastq
dataset
origin
sampl
prepar
sequenc
two
differ
laboratori
nibscmultiplexa
prepar
sequenc
laboratori
nibscmultiplexb
prepar
sequenc
laboratori
e
although
rt
includ
one
duplic
result
show
particip
consist
perform
much
wors
sampl
nibscmultiplexb
sampl
nibscmultiplexa
figur
interestingli
averag
perform
pipelin
nibscmultiplexa
similar
pipelin
increment
averag
perform
pipelin
nibscmultiplexb
similar
pipelin
e
increment
altogeth
result
strongli
suggest
sampl
prepar
larg
impact
overal
pipelin
perform
possibl
explan
observ
differ
perform
look
sampl
prepar
pipelin
e
could
nucleas
pretreat
includ
pipelin
e
tabl
futur
rt
would
interest
test
impact
sampl
prepar
sever
duplic
even
triplic
given
sampl
note
howev
nibscmultiplexa
particip
gener
achiev
good
perform
still
vari
notabl
across
pipelin
figur
mostli
due
variabl
precis
shown
thu
bioinformat
methodolog
also
strong
impact
overal
perform
order
investig
much
sampl
prepar
may
drive
overal
perform
also
compar
particip
perform
increment
compar
increment
spike
sampl
figur
increment
dataset
provid
laboratori
e
increment
dataset
provid
laboratori
respect
perform
sampl
increment
interestingli
still
observ
great
variabl
perform
increment
across
pipelin
driven
high
variabl
precis
shown
suggest
bioinformat
methodolog
also
strong
impact
overal
perform
particular
capabl
avoid
call
fals
posit
taken
togeth
result
suggest
sequenc
deep
enough
achiev
coverag
virus
necessari
suffici
achiev
high
sensit
precis
still
observ
great
variabl
perform
across
differ
bioinformat
workflow
mention
variabl
observ
rt
often
aros
differ
precis
rather
sensit
figur
show
famili
fals
posit
virus
identifi
pipelin
neg
sampl
increment
nibscneg
apart
pipelin
h
report
viru
neg
sampl
observ
remain
pipelin
report
least
two
virus
variou
famili
wonder
extent
fals
posit
due
laboratori
contamin
may
correct
use
appropri
neg
control
experiment
sequenc
carryov
index
hop
bioinformat
map
procedur
note
particip
use
sibprovid
databas
virus
may
decid
use
contamin
databas
also
provid
figur
show
result
obtain
nibscneg
sampl
increment
time
fastq
dataset
particip
sequenc
increment
pipelin
cf
tabl
interestingli
fals
posit
stem
laboratori
experiment
contamin
would
expect
pipelin
call
fals
posit
inde
case
two
famili
virus
polyomavirida
adenovirida
consist
report
pipelin
present
neg
sampl
remain
famili
fals
posit
virus
howev
report
pipelin
suggest
may
aris
bioinformat
workflow
per
se
particular
note
pipelin
h
report
two
famili
virus
report
everyon
fals
posit
thu
even
absenc
neg
control
run
alongsid
sampl
like
explain
absenc
fals
posit
report
increment
pipelin
h
also
seem
tune
achiev
low
number
fals
posit
one
aim
rt
test
import
refer
sequenc
databas
use
mapclassifi
read
taxonom
compar
mappingclassif
algorithm
thu
increment
sib
provid
common
databas
contain
whole
genom
sequenc
virus
known
contamin
bacteria
fungi
host
etc
particip
ask
perform
analys
common
databas
sib
addit
use
inhous
databas
figur
show
obtain
five
pipelin
particip
increment
use
sib
inhous
databas
result
show
signific
differ
perform
given
pipelin
use
sib
compar
inhous
databas
mannwhitney
u
test
suggest
rt
mappingclassif
algorithm
drive
overal
perform
rather
refer
sequenc
databas
use
along
algorithm
note
signal
driven
differenti
perform
precis
across
pipelin
rather
sensit
figur
size
use
databas
term
number
viral
sequenc
impact
overal
perform
either
shown
learn
sever
lesson
implement
pilot
viral
metagenom
ring
trial
particular
want
emphas
need
use
ncbi
access
number
togeth
regular
express
tabl
ncbi
taxonomi
order
correctli
assign
report
viru
taxonom
resolut
interest
specieslevel
case
inde
clinic
practic
laboratori
use
differ
name
viru
observ
sometim
report
viru
common
name
despit
identifi
speci
level
make
report
readerfriendli
clinician
establish
ring
trial
therefor
import
clearli
ask
particip
report
virus
detail
resolut
level
possibl
provid
mean
report
eg
ncbi
taxonomi
ncbi
access
number
particular
import
sinc
viral
taxonomi
consist
defin
thu
ask
viru
identif
may
mean
differ
taxonom
name
level
differ
laboratori
depend
viru
report
access
number
use
retriev
viru
full
name
ask
belong
expect
list
virus
chosen
resolut
level
sens
also
essenti
list
allow
name
expect
virus
chosen
resolut
level
made
avail
profici
test
particip
review
cf
tabl
ring
trial
increment
also
decid
ask
particip
directli
indic
metric
file
virus
would
report
clinician
produc
report
alway
mention
ncbi
access
number
ring
trial
base
spike
plasma
sampl
result
figur
suggest
context
depth
per
viru
achiev
pipelin
may
ration
target
high
qualiti
output
result
achiev
sequenc
depth
per
report
viru
howev
difficult
alway
feasibl
especi
sampl
plasma
higher
biomass
low
replic
virus
thu
other
suggest
use
nonoverlap
read
distinct
genom
region
criterion
report
virus
cerebrospin
fluid
sampl
ultim
target
depth
coverag
might
like
depend
envis
applic
type
sampl
may
also
consequ
expect
term
sensit
precis
sampl
process
step
bioinformat
tool
interpret
criteria
may
need
finetun
accordingli
compens
eg
lower
depth
coverag
per
viru
applic
result
perform
criteria
notabl
accredit
set
may
end
applicationspecif
extent
requir
eg
addit
complementari
valid
test
confirm
metagenom
result
discuss
identif
viral
enceph
meningoenceph
mening
end
import
bear
mind
clinic
metagenom
assay
like
use
alon
systemat
firstlin
test
rather
combin
diagnost
test
togeth
let
clinician
take
best
decis
patient
ring
trial
particip
gener
result
common
sibprovid
databas
addit
use
inhous
databas
refer
viral
sequenc
one
aim
assess
impact
databas
compar
algorithm
perform
interestingli
observ
databas
provid
enabl
particip
get
good
result
would
get
use
inhous
databas
figur
one
reason
find
may
particip
laboratori
hire
bioinformatician
dedic
resourc
semiautomaticallyautomat
refin
intern
databas
simpli
download
ncbi
virus
like
achiev
alreadi
good
qualiti
databas
similar
one
provid
thu
set
ie
rather
common
virus
swiss
clinic
context
appear
impact
databas
rather
low
overal
perform
howev
unclear
generaliz
find
may
given
limit
number
test
virus
sampl
small
number
particip
laboratori
sinc
test
sever
databas
vari
qualiti
would
still
recommend
take
advantag
expert
curat
databas
publish
cf
materi
method
refer
therein
optim
speed
bioinformat
workflow
decreas
fals
posit
call
gener
cf
figur
also
increas
sensit
less
sequenc
virus
gener
implement
futur
ring
trial
find
provid
common
databas
necessari
long
inhous
databas
particip
includ
ncbi
access
number
enabl
track
viru
desir
taxonom
level
ring
trial
design
way
ground
truth
alway
known
increment
practic
abl
assess
precis
sensit
increment
came
caveat
sampl
necessarili
reproduc
clinic
condit
although
tri
much
possibl
replic
real
condit
notabl
use
plasma
human
donor
hand
nibsc
viral
multiplex
control
clearli
come
close
real
clinic
scenario
may
explain
observ
much
lower
perform
sampl
due
high
number
virus
sampl
highlight
much
context
sampl
patient
also
essenti
guid
interpret
viral
metagenom
result
also
found
inform
use
sampl
increment
increment
also
duplic
time
provid
common
fastq
dataset
particip
pick
one
particip
increment
anonym
header
surprisingli
laboratori
pick
fastq
dataset
notic
perform
achiev
increment
alway
replic
increment
despit
start
ident
fastq
file
notabl
highlight
import
human
interpret
end
bioinformat
workflow
inde
particip
indic
clear
interpret
criteria
eg
minimum
absolut
number
read
map
viru
minimum
number
nonoverlap
read
minimum
percentag
coverag
addit
manual
inspect
sever
particip
also
mention
perform
manual
inspect
interestingli
depth
coverag
mention
one
report
criteria
although
observ
increment
figur
depth
coverag
beyond
associ
top
perform
could
howev
reproduc
find
increment
figur
perhap
highlight
fact
workflow
optim
whole
ie
sampl
report
separ
block
eg
laboratori
procedur
bioinformat
workflow
find
perhap
question
util
perform
ring
trial
assess
one
part
workflow
eg
start
common
fastq
dataset
anoth
perspect
also
highlight
particip
cautiou
analyz
data
origin
laboratori
ultim
human
interpret
like
substanti
impact
overal
perform
sens
also
suggest
clinic
viral
commun
share
interpret
report
practic
order
harmon
practic
increas
overal
knowledg
expertis
share
impact
human
review
observ
one
pipelin
reproduc
find
start
ident
fastq
dataset
also
call
individu
laboratori
clearli
defin
intern
standard
interpret
criteria
would
help
reduc
impact
differenti
human
review
like
essenti
accredit
context
ensur
result
reproduc
time
due
design
ring
trial
particip
ring
trial
possibl
use
neg
control
repres
sampl
test
sinc
lack
inform
increment
pipelin
e
f
h
j
nevertheless
use
intern
control
alongsid
provid
sampl
figur
pipelin
h
use
neg
control
water
submit
whole
ng
process
wherea
pipelin
e
f
j
use
well
character
sampl
intern
control
weak
posit
one
viru
pipelin
howev
pipelin
h
correctli
identifi
neg
sampl
neg
thu
abl
correctli
deplet
real
contamin
data
ad
typei
error
due
wrong
mappingclassif
bioinformat
step
pipelin
e
f
j
howev
still
report
virus
neg
sampl
suggest
may
aris
mostli
typei
error
bioinformat
step
increment
figur
also
observ
like
laboratori
contamin
typei
error
affect
particip
fals
posit
rate
sens
alway
run
neg
control
alongsid
certainli
good
practic
deplet
laboratori
contamin
suffici
avoid
fals
posit
call
bioinformat
step
nowaday
ng
viral
diagnost
brink
use
routin
laboratori
current
perform
viral
metagenom
nonaccredit
context
increas
number
laboratori
implement
ng
shotgun
metagenom
call
qualiti
manag
implement
ring
trial
benchmark
differ
pipelin
ensur
compar
result
across
site
term
perform
within
clinicallyrealist
cost
turnaround
time
ultim
particip
ring
trial
essenti
laboratori
get
accredit
use
shotgun
metagenom
viral
diagnost
today
ring
trial
profici
test
put
place
particular
focu
viral
pathogen
metagenom
mention
initi
led
compar
collabor
manag
platform
detect
analys
emerg
foodborn
outbreak
europ
involv
real
sampl
sewag
stool
artifici
insilico
gener
dataset
ii
ring
trial
netherland
pilot
phase
base
eight
clinic
sampl
assess
variabl
sampl
prepar
well
dna
rna
extract
sequenc
data
analyz
singl
common
bioinformat
workflow
idbydnaumcg
person
commun
iii
studi
spike
plasma
sampl
artifici
insilicogener
dataset
initi
pilot
studi
pave
way
standard
qualiti
control
clinic
viral
metagenom
order
get
pilot
studi
productionlevel
ensur
particip
take
advantag
ring
trial
laboratori
accredit
find
would
import
consid
implement
ring
trial
isoaccredit
framework
notabl
join
forc
certifi
organ
current
run
eqa
clinic
microbiolog
